13th International Conference on Environmental Mutagens

Maintaining Genomic Health in a Changing World

53rd Annual Meeting of the EMGS

August 27 - September 1, 2022 - Ottawa Canada



ICEM 2022 Sponsors

Become a Sponsor  

Diamond Level: 
Morningside Foundation
NIEHS R13 Grant No. 5R13ES031435-03 
TwinStrand Biosciences

Platinum Level:
Escher Fund for Autism 

Health and Environmental Sciences Institute
Proctor & Gamble, Co. 
US-FDA R13 Grant No. 5R13FD006702-04
University of Ottawa 
MGI Americas Inc.
Carleton University

Gold Level:
Bristol Myers Squibb
Canadian Institutes for Health Research
Inotiv Inc.

Silver Level:
Burroughs Wellcome Fund

United Kingdom Environmental Mutagen Society
Gilead Sciences
National Cancer Institute (NCI)
Merck Research

Bronze Level:
Lhasa Limited
The Research Institute for Fragrance Materials

Moltox, Molecular Toxicology, Inc. 
BASF Corp.
Toxys B.V.
Litron Laboratories
Kao Corporation


Johnson & Johnson
University of Michigan
John J. Nicolette, MS, DABT

European Environmental Mutagenesis and Genomics Society

Japanese Environmental Mutagen and Genome Society
Journal of Biochemistry
Pfizer Inc.
Environmental and Molecular Mutagenesis Journal 
Bill Kaufmann, PhD
Genetic Toxicology Association
Society of Toxicology



DNA Repair SIG Meeting: 7AM to 8AM | Governor General I - Level 4 | View Agenda
Chair: Aishwarya Prakash, PhD, University of South Alabama, Mobile, AL, USA
Co-Chair: Amy Michelle Whitaker, PhD, Fox Chase Cancer Center, Philadelphia, PA, USA

SNI Co-Chari: Ryan Barnes, PhD, University of Pittsburgh, Pittsburgh, PA, USA 

Germ Cell and Heritable Effects SIG Meeting: 7AM to 8AM | Governor General II - Level 4 | View Agenda
Chair:  Jonatan Axelsson, MD, PhD, Lund University and Skåne University Hospital, Malmö, Sweden

Co-Chairs: Habib A. Shojaei Saadi DVM, PhD, Health Canada, Ottawa, ON, Canada, Mathia L Colwell, University of Minnesota, St. Paul, MN, USA


Genomics and Data Sciences SIG Meeting: 7AM to 8AM | Governor General I - Level 4 View Agenda

Co-Chairs: Matthew Meier, Health Canada, Ottawa, ON, Canada, Christopher Faulk, PhD, University of Minnesota, St. Paul, MN, USA, Tess C Leuthner, Duke University, Durham, NC, USA

Applied Genetic Toxicology SIG Meeting: 7AM to 8AM | Governor General II - Level 4
Chair: Daniel J Roberts, MS, Charles River Laboratories, Skokie, IL, USA
Co-Chair: Alexandra S. Long, PhD, Health Canada, Ottawa, ON, USA

SNI Co-Chair: Eunnara Cho, Health Canada, Ottawa, ON, USA


Genotoxicity Risk Assessment and Public Health SIG Meeting: 7AM to 8AM | Governor General I - Level 4 | View Agenda
Chair: Catherine Gibbons, PhD, US EPA, Washington D.C., USA

Co-Chairs: Marc Andrew Beal, PhD, MSc & Julie Cox, Health Canada, Ottawa, ON, Canada, 

In Vivo Mutagenesis SIG Meeting: 7AM to 8AM | Governor General II - Level 4 | View Agenda
Chair: Mark Fielden, PhD, Kate Therapeutics, San Diego, CA, USA

Co-Chairs: Charles C Valentine, III, M.Sc., TwinStrand Biosciences, Seattle, WA, USA, Shaofei Zhang, Pfizer, Groton, CT, USA


Epigenomics SIG Meeting: 7AM to 8AM | Governor General I - Level 4 | View Agenda
Chair: Isabelle R. Miousse, PhD, University of Arkansas for Medical Sciences, Little Rock, AR, USA
Co-Chair: Brian N Chorley, PhD, US EPA, Raleigh, NC, USA
SNI Co-Chair: Nicole Wanner, DVM, University of Minnesota Twin Cities, St. Paul, MN, USA